Brief: China is no longer strategic for Diasorin, CEO says
14/03/2025 17:45
March 14 (Reuters) - DiaSorin CEO Carlo Rosa tells analysts: CHINA IS NO LONGER STRATEGIC FOR THE COMPANY SEES 2025 DOUBLE-DIGIT REVENUE GROWTH IN US AND HIGH SINGLE-DIGIT IN EUROPE CURRENT GUIDANCE INCLUDES NEW TARIFFS IN U.S., CHINA, CANADA, MEXICO Further company coverage: DIAS.MI ((gianluca.semeraro@tr.com; +39 06 80 307 741;))
Recent news on DiaSorin SpA
See all newsKepler sees European Medtech recovery, starts BioMerieux at 'Buy' as top pick
Brief: Diasorin Receives Us' FDA 510(K) Clearance And Clia Waiver For Liaison Nes Group A Streptococcus (Gas) Assay
Deutsche Bank cuts Diasorin to 'sell', sees company targets as stretched
Italy - Factors to watch on June 5
Italy's DiaSorin jumps after Betaville reports possible takeover interest